Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel

Published:2021-08-03 Issue:10 Volume:10 Page:1255-1266
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Krishnan Sreenath M.¹,Friberg Lena E.¹,Bruno René²,Beyer Ulrich³,Jin Jin Y.⁴,Karlsson Mats O.¹

Affiliation:

1. Department of Pharmacy Uppsala University Uppsala Sweden

2. Clinical Pharmacology, Roche/Genentech Marseille France

3. Biostatistics, F. Hoffmann‐La‐Roche Ltd Basel Switzerland

4. Clinical Pharmacology Roche/Genentech South San Francisco California USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12693

Reference40 articles.

1. Population pharmacokinetic–pharmacodynamic modelling in oncology: a tool for predicting clinical response

2. Progress and Opportunities to Advance Clinical Cancer Therapeutics Using Tumor Dynamic Models

3. New Guidelines to Evaluate the Response to Treatment in Solid Tumors

4. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

5. PKPD Modeling of Predictors for Adverse Effects and Overall Survival in Sunitinib-Treated Patients With GIST

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pharmacometric multistate model for predicting long-term treatment outcomes of patients with pulmonary TB;Journal of Antimicrobial Chemotherapy;2024-08-01

2. Extending the code in the open-source saemix package to fit joint models of longitudinal and time-to-event data;Computer Methods and Programs in Biomedicine;2024-04

3. Application of multistate modeling to clinical data analysis;CPT: Pharmacometrics & Systems Pharmacology;2024-02-12

4. Model‐Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen;Clinical Pharmacology & Therapeutics;2024-01-16

5. A multistate platform model for time‐to‐event endpoints in oncology clinical trials;CPT: Pharmacometrics & Systems Pharmacology;2023-11-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3